161 related articles for article (PubMed ID: 9414295)
1. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function.
Heinrich MC; Hoatlin ME; Zigler AJ; Silvey KV; Bakke AC; Keeble WW; Zhi Y; Reifsteck CA; Grompe M; Brown MG; Magenis RE; Olson SB; Bagby GC
Blood; 1998 Jan; 91(1):275-87. PubMed ID: 9414295
[TBL] [Abstract][Full Text] [Related]
2. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.
Kupfer GM; D'Andrea AD
Blood; 1996 Aug; 88(3):1019-25. PubMed ID: 8704210
[TBL] [Abstract][Full Text] [Related]
3. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.
Kruyt FA; Dijkmans LM; van den Berg TK; Joenje H
Blood; 1996 Feb; 87(3):938-48. PubMed ID: 8562965
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase.
Kruyt FA; Dijkmans LM; Arwert F; Joenje H
Cancer Res; 1997 Jun; 57(11):2244-51. PubMed ID: 9187128
[TBL] [Abstract][Full Text] [Related]
5. Fanconi anemia group A and D cell lines respond normally to inhibitors of cell cycle regulation.
Johnstone P; Reifsteck C; Kohler S; Worland P; Olson S; Moses RE
Somat Cell Mol Genet; 1997 Nov; 23(6):371-7. PubMed ID: 9661700
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea induces chromosomal damage in G2 and enhances the clastogenic effect of mitomycin C in Fanconi anemia cells.
Molina B; Marchetti F; Gómez L; Ramos S; Torres L; Ortiz R; Altamirano-Lozano M; Carnevale A; Frias S
Environ Mol Mutagen; 2015 Jun; 56(5):457-67. PubMed ID: 25663157
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
[TBL] [Abstract][Full Text] [Related]
9. The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells.
Marathi UK; Howell SR; Ashmun RA; Brent TP
Blood; 1996 Sep; 88(6):2298-305. PubMed ID: 8822951
[TBL] [Abstract][Full Text] [Related]
10. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.
Otsuki T; Wang J; Demuth I; Digweed M; Liu JM
Int J Hematol; 1998 Apr; 67(3):243-8. PubMed ID: 9650445
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
[TBL] [Abstract][Full Text] [Related]
12. BIK (NBK) is a mediator of the sensitivity of Fanconi anaemia group C lymphoblastoid cell lines to interstrand DNA cross-linking agents.
Prieto-Remón I; Sánchez-Carrera D; López-Duarte M; Richard C; Pipaón C
Biochem J; 2012 Nov; 448(1):153-63. PubMed ID: 22873408
[TBL] [Abstract][Full Text] [Related]
13. Fanconi anemia cells with unrepaired DNA damage activate components of the checkpoint recovery process.
Rodríguez A; Torres L; Juárez U; Sosa D; Azpeitia E; García-de Teresa B; Cortés E; Ortíz R; Salazar AM; Ostrosky-Wegman P; Mendoza L; Frías S
Theor Biol Med Model; 2015 Sep; 12():19. PubMed ID: 26385365
[TBL] [Abstract][Full Text] [Related]
14. Interaction of FANCD2 and NBS1 in the DNA damage response.
Nakanishi K; Taniguchi T; Ranganathan V; New HV; Moreau LA; Stotsky M; Mathew CG; Kastan MB; Weaver DT; D'Andrea AD
Nat Cell Biol; 2002 Dec; 4(12):913-20. PubMed ID: 12447395
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia.
Seyschab H; Friedl R; Sun Y; Schindler D; Hoehn H; Hentze S; Schroeder-Kurth T
Blood; 1995 Apr; 85(8):2233-7. PubMed ID: 7718895
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model.
Tomkins DJ; Care M; Carreau M; Buchwald M
Mutat Res; 1998 Jul; 408(1):27-35. PubMed ID: 9678061
[TBL] [Abstract][Full Text] [Related]
17. Arrest of S-phase progression is impaired in Fanconi anemia cells.
Sala-Trepat M; Rouillard D; Escarceller M; Laquerbe A; Moustacchi E; Papadopoulo D
Exp Cell Res; 2000 Nov; 260(2):208-15. PubMed ID: 11035915
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
[TBL] [Abstract][Full Text] [Related]
19. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
[TBL] [Abstract][Full Text] [Related]
20. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
